CasalinoLP. Markets and medicine: barriers to creating a “business case for quality.” Perspect Biol Med
MurphyDM. From expert data collectors to interventionists: changing the focus for infection control professionals. Am J Infect Control
BurkeJP. Infection control—a problem for patient safety. New Engl J Med
CalfeeDP, FarrBM. Infection control and cost control in the era of managed care. Infect Control Hosp Epidemiol
MurphyDM, AlvaradoCI, FawalH. The business of infection control and epidemiology. Am J Infect Control
WrightSB, OstrowskyB, FishmanN, et al. Hospital epidemiology and infection control roles expanding despite limited resources and compensation. In: Program and abstracts of the 17th Annual Scientific Meeting of the Society for Healthcare Epidemiology in America (Baltimore). 2007 (Abstract 55).
HefflerS, SmithS, KeehanS, BorgerC, ClemensMK, TrufferC. US health spending projections for 2004-2014. Health Aff (Millwood) 2005;suppl Web exclusives:W5-74-W5-85.
StonePW, SchackmanBR, NeukermansCP, et al. A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis
DrummondMF, SculpherMJ, TorranceGW, O'BrienBJ, StoddartGL. Methods for the Economic Evaluation of Health Care Programmes. 7th ed. Oxford: Oxford University Press;2005.
GoldMR, SiegelJE, RussellLB, WeinsteinMC. Cost-Effectiveness in Health and Medicine. 1st ed. New York, NY: Oxford University Press;1996.
PetittiDB. Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis. 2nd ed. New York: Oxford University Press;2000.
LeathermanS, BerwickD, IlesD, et al. The business case for quality: case studies and an analysis. Health Aff (Millwood)
StonePW, BracciaD, LarsonE. Systematic review of economic analyses of health care-associated infections. Am J Infect Control
MansleyEC, McKennaMT. Importance of perspective in economic analyses of cancer screening decisions. Lancet
McGregorJC, WeekesE, ForrestGN, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc
HarrisAD, BradhamDD, BaumgartenM, ZuckermanIH, FinkJC, PerencevichEN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis
McConkeySJ, L'EcuyerPB, MurphyDM, LeetTL, SundtTM, FraserVJ. Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol
DietrichES, DemmlerM, SchulgenG, et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection
HugonnetS, EggimannP, BorstF, MaricotP, ChevroletJC, PittetD. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol
WarrenDK, ShuklaSJ, OlsenMA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med
RelloJ, OllendorfDA, OsterG, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest
SafdarN, DezfulianC, CollardHR, SaintS. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med
BlotSI, DepuydtP, AnnemansL, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis
DigiovineB, ChenowethC, WattsC, HigginsM. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med
RelloJ, OchagaviaA, SabanesE, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med
CoelloR, CharlettA, WilsonJ, WardV, PearsonA, BordelloP. Adverse impact of surgical site infections in English hospitals. J Hosp Infect
CoskunD, AytacJ, AydinliA, BayerA. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect
HollenbeakCS, MurphyDM, KoenigS, WoodwardRS, DunaganWC, FraserVJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest
JenneyAW, HarringtonGA, RussoPL, SpelmanDW. Cost of surgical site infections following coronary artery bypass surgery. ANZ J Surg
TambyahPA, KnasinskiV, MakiDG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol
LaiKK, FontecchioSA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control
DimickJB, WeeksWB, KariaRJ, DasS, CampbellDAJr. Who pays for poor surgical quality? Building a business case for quality improvement. J Am Coll Surg
WardWJJr, SpragensL, SmithsonK. Building the business case for clinical quality. Healthc Financ Manage
RobertsRR, FrutosPW, CiavarellaGG, et al. Distribution of variable vs fixed costs of hospital care. JAMA
US Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare and Medicaid statistical supplement: details for Medicare short-stay hospitals. Available at: http://www.cms.hhs.gov. Accessed July 17, 2007.
WrightMO, HebdenJN, HarrisAD, et al. Aggressive control measures for resistant Acinetobacter haumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unit. Infect Control Hosp Epidemiol
GuinanJL, McGuckinM, ShubinA, TigheJ. A descriptive review of malpractice claims for health care-acquired infections in Philadelphia. Am J Infect Control
JulianKG, BrumbachAM, ChicoraMK, et al. First year of mandatory reporting of healthcare-associated infections, Pennsylvania: an infection control-chart abstractor collaboration. Infect Control Hosp Epidemiol
LindenauerPK, RemusD, RomanS, et al. Public reporting and pay for performance in hospital quality improvement. New Engl J Med
PerencevichEN, FismanDN, LipsitchM, HarrisAD, MorrisJGJr, SmithDL. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis
GinterPM, SwayneLE, DuncanWJ. Strategic Management of Health Care Organizations. 4thed. Maiden, MA: Blackwell Publishing Ltd.;2002.
DooleyRS, FryxellGE, JudgeWQ. Belaboring the not-so-obvious: consensus, commitment, and strategy implementation speed and success. J Management
ZanettiG, GoldieSJ, PiattR. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery. Emerg Infect Dis
NeumannPJ. Using Cost-Effectiveness Analysis to Improve Health Care. 1st ed. New York, NY: Oxford University Press;2005.
KoplanJP, HarpazR. Shingles vaccine: effective and costly or cost-effective?
Ann Intern Med
BellCM, UrbachDR, RayJG, et al. Bias in published cost effectiveness studies: systematic review. BMJ
US Department of Labor, Bureau of Labor Statistics. Consumer Price Index, 2006. Available at: http://www.bls.gov/cpi/home.htm. Accessed April 29, 2007.
US Department of Labor, Bureau of Labor Statistics. Consumer Price Index inflation calculator. Available at: http://data.bls.gov/cgi-bin/cpicalc.pl. Accessed April 29, 2007.
US Department of Labor, Bureau of Labor Statistics (BLS). How BLS measures price change for medical care services in the Consumer Price Index. March 1, 2007. Available at: http://www.bls.gov/cpi/cpifact4.htm. Accessed April 29, 2007.
KeelerE, CretinS. Discounting of life-savings and other non-monetary effects. Management Sei
CarmeliY, CosgroveSE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis
KayeKS, EngemannJJ, MozaffariE, CarmeliY. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis
SchulgenG, KropecA, KappsteinI, DaschnerF, SchumacherM. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol
KnausWA, DraperEA, WagnerDP, ZimmermanJE. APACHE II: a severity of disease classification system. Crit Care Med
IezzoniLI. The risks of risk adjustment. JAMA
RobinsJM. The control of confounding by intermediate variables. Stat Med
PerencevichEN. Excess shock and mortality in Staphylococcus aureus related to methicillin resistance. Clin Infect Dis
SchwaberMJ, CarmeliY. Antimicrobial resistance and patient outcomes: the hazards of adjustment. Crit Care
CharlsonME, PompeiP, AlesKL, MacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis
Von KorffM, WagnerEH, SaundersK. A chronic disease score from automated pharmacy data. J Clin Epidemiol
BatistaR, KayeK, YokoeDS. Admission-specific chronic disease scores as alternative predictors of surgical site infection for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol
KayeKS, SandsK, DonahueJG, ChanKA, FishmanP, PlattR. Preoperative drug dispensing as predictor of surgical site infection. Emerg Infect Dis
McGregorJC, KimPW, PerencevichEN, et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol
McGregorJC, PerencevichEN, FurunoJP, et al. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol
PerencevichEN, SandsKE, CosgroveSE, GuadagnoliE, MearaE, PiattR. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis
CosgroveSE, CarmeliY. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis
HaleyRW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med
FinklerSA. The distinction between cost and charge. Ann Intern Med
PronovostP, AngusDC. Cost reduction and quality improvement: it takes two to tango. Crit Care Med
HowardD, CordellR, McGowanJEJr, PackardRM, ScottRD2nd, SolomonSL. Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop. Clin Infect Dis
AshbyJ. The accuracy of cost measures derived from Medicare cost report data, Intramural #1-93-01. Prospective Payment Assessment Commission. Washington, DC, 1993.
ShwartzM, YoungDW, SiegristR. The ratio of costs to charges: how good a basis for estimating costs?
LarsonE. State-of-the-science—2004: time for a “no excuses/no tolerance” (NET) strategy. Am J Infect Control
ClassenDC, EvansRS, PestotnikSL, HornSD, MenloveRL, BurkeJP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New Engl J Med
BensonK, HartzAJ. A comparison of observational studies and randomized, controlled trials. Neyv Engl J Med
ConcatoJ, ShahN, HorwitzRI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New Engl J Med
PocockSJ, ElbourneDR. Randomized trials or observational tribulations?
New Engl J Med
HayesRJ, AlexanderND, BennettS, CousensSN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res
KlarN, DonnerA. Current and future challenges in the design and analysis of cluster randomization trials. Stat Med
BennettS, ParpiaT, HayesR, CousensS. Methods for the analysis of incidence rates in cluster randomized trials. Int J Epidemiol
DonnerA, KlarN. Pitfalls of and controversies in cluster randomization trials. Am J Public Health
ElbourneDR, CampbellMK. Extending the CONSORT statement to cluster randomized trials: for discussion. Stat Med
MutoCA, GiannettaET, DurbinLJ, SimontonBM, FarrBM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus
. Infect Control Hosp Epidemiol
RaoN, JacobsS, JoyceL. Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol
ShadishWR, CookTD, CampbellDT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Boston: Houghton Mifflin Company;2002.
HarrisAD, LautenbachE, PerencevichE. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis
ShadishWR, HeinsmanDT. Experiments versus quasi-experiments: do they yield the same answer?
NIDA Res Monogr
AustinDJ, BontenMJ, WeinsteinRA, SlaughterS, AndersonRM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA
BergstromCT, LoM, LipsitchM. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci USA
BonhoefferS, LipsitchM, LevinBR. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA
BootsmaMC, DiekmannO, BontenMJ. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA
LipsitchM, CohenT, CooperB, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science
PerencevichEN, HartleyDM. Of models and methods: our analytic armamentarium applied to methicillin-resistant Staphylococcus aureus
. Infect Control Hosp Epidemiol
OstrowskyB, SteinbergJT, FarrB, SohnAH, Sinkowitz-CochranRL, JarvisWR. Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?
Infect Control Hosp Epidemiol
HuninkM, GlasziouP, SiegelJ, et al. Decision Making in Health and Medicine.
1st ed. Cambridge, United Kingdom: Cambridge University Press;2001.